中文字幕人成乱码熟女_亚洲熟女乱色综合亚洲图片_中文字幕av无码不卡免费_一本之道高清无码视频_性色av无码一区二区三区人妻

RNA藥物
Updated:2022/04/06


RNAi藥物

RNAi technology refers to highly conserved, double-stranded RNA induced, highly specific degradation of homologous mrnas in the evolutionary process, and is a post-transcriptional gene silencing (PTGS) that degrades mrnas.

The main mechanism of RNAi is that long double RNA is cleaved into short RNA and binds with protein to form siRNA-induced interference complex (RISC). After the degradation of the righteous strand of short RNA, RISC binds to specific mRNA to degrade the mRNA and eventually silences the expression of specific genes.

Known RNAi mainly include siRNA, miRNA and piRNA.


ASO藥物

ASO refers to a single strand of DNA or RNA sequence that is complementary to the mRNA of the target gene, usually consisting of a dozen to dozens of bases and produced by chemical synthesis.


After some specific chemical modifications of ASO, ASO drugs enter cells in a certain way and can specifically regulate the expression of target genes.


RNAi藥物、ASO藥物的作用機制

For the treatment of rare or refractory sexually transmitted diseases, cancer and genetic diseases at the genetic level.?ASO and RNAi therapy are similar in principle, both of which aim to degrade or inhibit sequentially complementary target mRNAs to achieve expression silencing of related genes.
The Previous: siRNA合成套餐
The Next:RNA原料

GIVE US A MESSAGE

PRODUCTS CENTER